MoonLake Immunotherapeutics reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
MoonLake Immunotherapeutics has filed 329 SEC EDGAR filings since 28 Aug 2020

SEC filing history

Showing 276-300 of 329 matching filings.

Per page
25
Current page
12
DEFA14A File 001-39630

DEFINITIVE ADDITIONAL MATERIALS

Filing date
19 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-39630

PROXY STATEMENT

Filing date
16 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-39630

AMENDMENT NO. 1 TO FORM 10-Q

Filing date
14 Dec 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
10-K/A File 001-39630

AMENDMENT NO. 1 TO FORM 10-K

Filing date
14 Dec 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
SC 13G File 005-91803

SC 13G filing

Filing date
10 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
03 Dec 2021
Reporting date
30 Nov 2021
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

SCHEDULE13G/A

Filing date
15 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39630

QUARTERLY REPORT

Filing date
12 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
PREM14A File 001-39630

PROXY STATEMENT

Filing date
29 Oct 2021
Reporting date
29 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39630

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIAL

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39630

CURRENT REPORT

Filing date
04 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
04 Oct 2021
Reporting date
04 Oct 2021
Next action
Verify source filing
10-Q File 001-39630

QUARTERLY REPORT

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-Q File 001-39630

QUARTERLY REPORT

Filing date
21 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
NT 10-Q File 001-39630

NOTIFICATION OF LATE FILING

Filing date
18 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
03 May 2021
Reporting date
27 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39630

ANNUAL REPORT

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
SC 13G File 005-91803

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .